New Sanofi CEO Plans Strategic Review For Presentation In Fourth Quarter
This article was originally published in The Pink Sheet Daily
Executive Summary
Newly installed CEO Olivier Brandicourt plans a global assessment of Sanofi operations before deciding what to do, but will he have the support of the French drug maker’s all-important board to make changes?